Are essential oils and aromatherapy safe during pregnancy?
Safe in moderation — 1% dilution: 1 drop per 5ml carrier oil. Avoid direct use in the first trimester. Never ingest
Diluted on the skin or used in a diffuser, yes. NHS midwifery guidelines use a 1% dilution - one drop per 5ml of carrier oil - and avoid direct use in the first trimester. Never swallow them. No national regulator anywhere publishes pregnancy guidance on essential oils.
The verdict
Diluted, on the skin or in the air, yes. Neat on the skin, no. Swallowed, never.
The honest position is that this is the least regulated topic on the site. No national food or cosmetics regulator anywhere publishes pregnancy guidance on essential oils. The only written rules that exist are NHS maternity unit policies, and those are clinical protocols for midwives rather than consumer advice.
Those protocols converge on a workable answer: a 1% dilution - one drop of essential oil in 5ml of carrier oil - from a short list of oils, avoided in the first trimester as a precaution, with a handful of specific oils excluded in specific circumstances.
Why dilution is the whole answer
An essential oil is not a gentle plant extract. It is a steam-distilled concentrate of the volatile fraction of a plant, typically 100 to 200 times more concentrated than the plant material it came from, made up of small lipophilic molecules - terpenes, aldehydes, phenylpropanoids - with molecular weights around 150 to 250. Molecules that size and that fat-soluble cross skin readily, and anything that crosses skin readily crosses a placenta.
That is why the concentration matters more than the botanical name. At 1% in a carrier oil, applied to a limb during a massage, the absorbed dose is measured in milligrams. Neat lavender rubbed onto the skin is a different order of exposure entirely, and a swallowed teaspoon is a different order again.
The FDA makes the same point from the other direction, about the marketing rather than the chemistry: sometimes people think that if an essential oil or other ingredient comes from a plant, it must be safe. But many plants contain materials that are toxic, irritating, or likely to cause allergic reactions when applied to the skin. It gives cumin oil, safe in food but capable of blistering skin, as the example.
What is actually documented
Three categories of harm are established, and none of them is a fetal effect from ordinary diluted use:
- Skin sensitisation. Essential oils are among the more common causes of allergic contact dermatitis in cosmetics. Pregnancy skin is more reactive than usual, and an oil you have used for years can be the one that turns.
- Phototoxicity. Expressed citrus oils - bergamot above all - contain furocoumarins that react with UV and cause burns and long-lasting pigmentation. In pregnancy this compounds melasma, which is already the most common skin change of the second and third trimesters.
- Poisoning by ingestion. Essential oils are potent when swallowed and the volumes involved are small. Wintergreen oil is roughly 98% methyl salicylate; eucalyptus and camphor oils have caused serious poisoning in children at teaspoon doses. This is a household safety point, not a pregnancy one, but it is the reason the do-not-swallow rule is absolute.
What is not documented is the thing people worry about most. There is no controlled human evidence that any commonly used essential oil, used diluted and topically, causes miscarriage or malformation. The traditional claims that clary sage, jasmine and rose are emmenagogic - that they stimulate the uterus - are the basis for the first-trimester caution in NHS guidelines, and they rest on herbal tradition and animal work, not on trials in pregnant women. NHS guidance acts on them anyway, which is a defensible response to an absence of evidence rather than a finding of harm.
How much is too much
NHS midwifery aromatherapy guidelines give the concrete figures, and they are conservative:
- Massage dilution: 1 drop of essential oil in 5ml of carrier oil, a 1% dilution, scaling proportionally - up to 5 drops in 25ml.
- First trimester: avoid direct use. NHS Borders' guideline states plainly: avoid in the first trimester because some essential oils are emmenagogic.
- Restricted list: the oils used in NHS midwifery practice are a short set - bergamot, chamomile, clary sage, eucalyptus, frankincense, geranium, grapefruit, jasmine, lavender, lemon, mandarin, peppermint, petitgrain, rose and ylang ylang - not the whole shelf.
- Specific exclusions: clary sage, jasmine and rose are not to be used in threatened premature labour; clary sage and rose are excluded for women who have had previous uterine surgery; peppermint is avoided in diabetes and epilepsy.
- Diffusers: the lowest-exposure route, and the least studied. Ventilate, run it in sessions rather than continuously, and stop if it makes you nauseated - which in the first trimester it very well may.
Two practical rules that no guideline needs to state but everyone should follow: patch test on the inside of your forearm before using anything new on a larger area, and never apply expressed citrus oils to skin that will see daylight within 12 to 18 hours.
If you have already used them
Diluted, on the skin, or in a diffuser, in any trimester: nothing follows. There is no test, no monitoring and no recognised exposure event. The first-trimester caution in NHS guidelines is a precaution built on absent evidence, not a threshold that has been crossed.
If you applied an oil neat and the skin is red, itchy, blistered or spreading, that is contact dermatitis and it is worth a pharmacist or GP - in pregnancy or out of it. If you have a burn or dark patch where a citrus oil met sunlight, that is phototoxicity and it can take months to fade; keep it covered and out of the sun.
If anyone has swallowed an essential oil - you or, more likely, a child in the house - contact your national poisons service or emergency number immediately. Do not induce vomiting. Take the bottle with you.
Where the guidance differs by country
It does not differ, because with one exception nobody has written any.
The US regulates the claim, not the pregnancy. The FDA's position is that how an aromatherapy product is regulated depends on its intended use. Marketed only to make a person smell good or to cleanse the body, it is a cosmetic and needs no pre-market approval. Marketed to relieve colic, ease pain, relax muscles, treat anxiety or help you sleep, it is a drug and must meet drug requirements - and the fact that an ingredient comes from a plant does not exempt it. The FDA publishes nothing about pregnancy.
The EU and Great Britain regulate individual molecules. The Cosmetics Regulation restricts and in some cases prohibits specific essential oil constituents on toxicological grounds, and requires 26 fragrance allergens - several of them essential oil components - to be declared on the label. None of that framework mentions pregnancy anywhere.
Canada and Australia say nothing at all about essential oils in pregnancy in their food or cosmetic safety guidance.
The only written pregnancy rules in existence are British and local. Individual NHS boards and trusts publish aromatherapy guidelines for midwifery practice - which oils, which dilutions, which contraindications, whether the first trimester is excluded. They are internally consistent and they do not entirely agree with each other, because each is a local consensus document rather than a national standard. That is the true state of this topic: a national health service using aromatherapy routinely in maternity care, with no national guidance behind it and no regulator anywhere addressing the pregnancy question.
There is no national UK guidance. NHS boards publish their own aromatherapy guidelines for midwifery practice: NHS Borders' names 15 oils used in practice - bergamot, chamomile, clary sage, eucalyptus, frankincense, geranium, grapefruit, jasmine, lavender, lemon, mandarin, peppermint, petitgrain, rose and ylang ylang - and specifies a massage dilution of 1 drop of essential oil in 5ml of grapeseed oil, a 1% dilution, scaling to 5 drops in 25ml. It states: avoid in the first trimester because some essential oils are emmenagogic, and notes that aromatherapy oils have molecular weights around 250 and can cross the placenta. Clary sage, jasmine and rose are not to be used in threatened premature labour; clary sage and rose are excluded after previous uterine surgery; peppermint is avoided in diabetes and epilepsy.
Showing guidance from NHS Borders maternity guideline — read the source.
The FDA regulates aromatherapy products by intended use rather than by ingredient. A product intended only to cleanse the body or make a person smell good is a cosmetic and needs no pre-market approval; a product claiming to relieve colic, ease pain, relax muscles, treat depression or anxiety or help you sleep is a drug and must meet drug requirements, and the fact that a fragrance material comes from a plant does not keep it from being regulated as a drug. On safety it warns that many plants contain materials that are toxic, irritating, or likely to cause allergic reactions when applied to the skin, citing cumin oil, which is safe in food but can blister skin, and citrus oils, which can be harmful on skin exposed to sun. It publishes nothing about pregnancy.
Showing guidance from US Food and Drug Administration — read the source.
The Cosmetics Regulation retained in Great Britain and applied in the EU controls essential oils at the level of individual constituents rather than the oil, restricting or prohibiting specific molecules on toxicological grounds and requiring named fragrance allergens - many of which are essential oil components such as limonene, linalool, citral, geraniol and eugenol - to be declared in the ingredient list above set thresholds. The Regulation and its annexes contain no reference to pregnancy in relation to essential oils or aromatherapy.
Showing guidance from UK retained Cosmetics Regulation / European Commission — read the source.
Health Canada's Cosmetic Ingredient Hotlist restricts and prohibits named substances in cosmetics, including some plant-derived constituents, on general toxicological grounds. Neither the Hotlist nor Health Canada's consumer cosmetics guidance addresses essential oils in pregnancy, and Canada publishes no aromatherapy advice for pregnant women.
Showing guidance from Health Canada — read the source.
Sources
- Aromatherapy Guideline for Midwifery Practice — NHS Borders (Right Decisions for Health and Care), accessed
- Aromatherapy — US Food and Drug Administration, accessed
- Regulation (EC) No 1223/2009 on cosmetic products, Annex III — legislation.gov.uk (UK retained EU law), accessed
- Cosmetic Ingredient Hotlist: prohibited and restricted ingredients — Health Canada, accessed
- Complementary Therapies in Maternity Care Guideline — Milton Keynes University Hospital NHS Foundation Trust, accessed